Transferrin (Tf)-functionalized cobalamin-liposomes were reported to improve the CNS penetration of cobalamin, allowing it to effectively exert its anti-amyloidogenic activity, which is beneficial for treating Alzheimer’s disease (AD). The gene discussed is TF; the disease is early-onset autosomal dominant Alzheimer disease.